MedTrace Logo

Intravenous NTG to Preserve Gastric Microcirculation During Gastric Tube Reconstruction

NCT00335010 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2006-06-08

No results posted yet for this study

Summary

The aim of the present study was to investigate if NTG, administered intravenously during gastric tube reconstruction, could preserve gastric fundus tissue blood flow and oxygenation and reduce the incidence of postoperative leakage.

Conditions

  • Esophageal Neoplasms
  • Microcirculation

Interventions

DRUG

Nitroglycerin

Sponsors & Collaborators

Principal Investigators

  • Diederik Gommers, MD, PhD · Erasmus Medical Center

  • Marc Buise, MD · Erasmus Medical Center

  • Jasper van Bommel, MD, PhD · Erasmus Medical Center

  • Huug Tilanus, MD, PhD · Erasmus Medical Center

  • Khe Tran, MD · Erasmus Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Completion
2005-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00335010 on ClinicalTrials.gov